Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement.

Assié, Jean-Baptiste; Jean, Didier

Assié, Jean-Baptiste; Jean, Didier.

Affiliation

Assié JB; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Functional Genomics of Solid Tumors Laboratory, Paris, France.
Jean D; GRC OncoThoParisEst, Service de Pneumologie, Centre Hospitalier IntercommunaI, UPEC, Créteil, France.

Expert Opin Ther Targets ; 27(11): 1059-1069, 2023.

Article in En | MEDLINE | ID: mdl-37902459

Subject(s)

Lung Neoplasms; Mesothelioma, Malignant; Mesothelioma; Pleural Neoplasms; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms/pathology; Mesothelioma, Malignant/drug therapy; Mesothelioma/drug therapy; Mesothelioma/pathology; Pleural Neoplasms/drug therapy; Pleural Neoplasms/pathology; Immunotherapy

Key words

Personalized medicine; Pleural mesothelioma; cell therapy; immunotherapy; innovative therapeutics; oncovirotherapy; targeted therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Mesothelioma, Malignant / Lung Neoplasms / Mesothelioma Limits: Humans Language: En Journal: Expert Opin Ther Targets Journal subject: TERAPEUTICA Year: 2023 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google